Clade Therapeutics Email Format
Biotechnology ResearchMassachusetts, United States2-10 Employees
Clade Therapeutics is a biotechnology research company based in Boston, Massachusetts, at 201 Brookline Avenue Suite 1002, focusing on developing stem cell-based, off-the-shelf cell therapies for cancer and other serious diseases. The company has a small team, with between 2 and 10 employees. In 2021, Clade Therapeutics completed an $87 million Series A financing. In 2023, Clade Therapeutics completed the acquisition of Gadeta B.V. In February 2024, Century Therapeutics, LLC acquired Clade Therapeutics.